The anatomy of a drug website: 5 pharma tactics to be wary of
Cashing in on emotions: How pharma profits from medicalizing the normal spectrum of feelings
“Less is more” theme from breast cancer conference attracts little mainstream news coverage
Two steps forward, one step back: When health news overlooks active surveillance as treatment for prostate cancer
Will a major medical journal’s PR statement contribute to the overtreatment of back pain?
Why biotech celeb Craig Venter’s prostate cancer story should be read with healthy dose of skepticism
Overall impressive: News media coverage of NEJM study on treating vs not treating prostate cancer
Missing in action: Did US journalists miss a huge opportunity to critically examine mental health screening?
Some news from major breast cancer meeting needed more context
A patient’s perspective on recent prostate cancer screening news